Ivim Health Welcomes FDA’s Long-Overdue Step Toward Regulated Peptide Access
Anthony Kantor, Dr. Taylor Kantor, and Dr. Jessica Duncan — We applaud today’s announcement from Secretary Kennedy on peptide reclassification. This is meaningful news for the patients we serve every day. For too long, Americans interested in peptide therapy have had limited options … Read more